Developing The Pharmaceutical Guided Missile To Defeat Coronavirus Lung Infections

+ Market Ready CBD Derma Cosmetic Brand And Patent-Pending CBD Pain Relief Brand

Sponsored
Message: REMINDER: Innocan Pharma to Provide Corporate Update via Livestream Video Today at 10am EST

The company will provide a corporate update to the investment community and shareholders through a YouTube livestream video on today at 10:00am EST.

The update will include a corporate presentation by Innocan's CEO Iris Bincovich describing the key research milestones achieved by the company to date, and a scientific review by Innocan's Scientific Advisor Professor Daniel Offen.

The YouTube livestream video will be available through livestream.innocanpharma.com

Hub On AGORACOM / Read Recent Release...

Innocan Achieves Major Milestone in Developing Its Unique CBD-Loaded Liposome Platform Technology for Injectable CBD

  • Study on mice demonstrated a prolonged release of Cannabidiol into the blood for at least three weeks after one administration
  • Conducted based on Innocan’s licensed CBD loaded liposome platform technology for injectable CBD
  • Conducted on over 35 mice and found significant amounts of CBD in the mice’s blood 21 days after they were injected with a single injection of liposomal CBD using Innocan’s CBD loaded LPT
  • Results are substantial when comparing the oral or smoking administration of CBD, in which CBD was found in the blood of mice only for a period of up to 36 hours after one administration
  • Results open the door for future experiments to prove the lack of toxicity and beneficial therapeutic efficacy of the formulations.
Share
New Message
Please login to post a reply